Catalyst Pharmaceutical CPRX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Catalyst Pharmaceutical's earnings yield?
- Catalyst Pharmaceutical (CPRX) reported earnings yield of 7.3% in Q1 2026.
- How has Catalyst Pharmaceutical's earnings yield changed year-over-year?
- Catalyst Pharmaceutical's earnings yield increased by 9.2% year-over-year, from 6.7% to 7.3%.
- What is the long-term trend for Catalyst Pharmaceutical's earnings yield?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's earnings yield has grown at a -19.3% compound annual growth rate (CAGR), from 21.8% to 7.5%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.